Whalegun
Home

David Bredt, Chief Scientific Officer: Rapport Therapeutics RAPP Sell · Filed 02/19

Trade details

Type
Insider sale
Amount
$156,330
Shares · price
5,400 sh · $28.95 a share
Held after
389,275 sh
Stock
Rapport Therapeutics RAPP
Person
David BredtChief Scientific Officer
Trade date
26/02/17
Filed
26/02/19
Days to filing
2 days

Sold 1.4% of holdings

Share of holding sold
1.4%

Rapport Therapeutics trades, last 26 weeks

What else happened in Rapport Therapeutics around then

Filed or reported within 30 days of the trade day · 01/18~03/19

David Bredt's recent trades

  • David Bredt

    Sell10b5-1 planRapport Therapeutics

    $65.1K

    Filed 02/19

  • David Bredt

    Sell10b5-1 planRapport Therapeutics

    $25.2K

    Filed 02/19

  • David Bredt

    Sell10b5-1 planRapport Therapeutics

    $222.7K

    Filed 01/16

  • David Bredt

    Sell10b5-1 planRapport Therapeutics

    $5,480

    Filed 01/16

  • David Bredt

    Planned sale10b5-1 planRapport Therapeutics

    $466.1K

    Filed 01/15

David Bredt, Chief Officer — sold $156.3K of Rapport Therapeutics RAPP · 1.4% of holdings · 10b5-1 plan | Whalegun